1. S. B. Matin, S. H. Wan, and J. H. Karam. Pharmacokinetics of tolbutamide: Prediction by concentration in saliva.Clin. Pharmacol. Ther. 16:1052–1058 (1974).
2. W. Kalow.Pharmacogenetics: Heredity and the Response to Drugs, Saunders, Philadelphia, 1962, pp. 95–104.
3. J. H. Peters, K. S. Miller, and P. Brown. Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man.J. Pharmacol. Exp. Ther. 150:298–304 (1965).
4. G. A. Ellard, P. T. Gammon, S. Lakshiminarayan, W. Fox, V. R. Aber, D. A. Mitchison, K. M. Citron, and R. Tall. Pharmacology of some slow-release preparations of isoniazid of potential use in intermittent treatment of tuberculosis.Lancet, 340–343 (1972).
5. J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, 1st ed., Drug Intelligence Publications, Hamilton, Ill., 1971, pp. 182, 244.